PFG Advisors boosted its position in CME Group Inc (NASDAQ:CME) by 3.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 7,570 shares of the financial services provider’s stock after purchasing an additional 260 shares during the period. PFG Advisors’ holdings in CME Group were worth $1,629,000 as of its most recent filing with the SEC.
A number of other large investors have also recently modified their holdings of the stock. Windward Capital Management Co. CA lifted its stake in CME Group by 1.5% in the 3rd quarter. Windward Capital Management Co. CA now owns 102,182 shares of the financial services provider’s stock valued at $21,595,000 after purchasing an additional 1,540 shares during the last quarter. YHB Investment Advisors Inc. lifted its position in CME Group by 3.3% during the third quarter. YHB Investment Advisors Inc. now owns 30,793 shares of the financial services provider’s stock worth $6,508,000 after acquiring an additional 975 shares during the last quarter. Gyroscope Capital Management Group LLC lifted its position in CME Group by 12.9% during the third quarter. Gyroscope Capital Management Group LLC now owns 2,315 shares of the financial services provider’s stock worth $485,000 after acquiring an additional 265 shares during the last quarter. Rockland Trust Co. acquired a new stake in CME Group during the third quarter worth approximately $449,000. Finally, Pacer Advisors Inc. lifted its position in CME Group by 13.6% during the third quarter. Pacer Advisors Inc. now owns 38,437 shares of the financial services provider’s stock worth $8,123,000 after acquiring an additional 4,606 shares during the last quarter. Institutional investors and hedge funds own 84.92% of the company’s stock.
Several equities research analysts have issued reports on the stock. ValuEngine downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Wells Fargo & Co raised their price objective on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Oppenheimer assumed coverage on shares of CME Group in a research report on Monday, September 16th. They set an “outperform” rating and a $234.00 price objective for the company. Berenberg Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $236.00 to $227.00 in a research report on Thursday, September 19th. Finally, BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research report on Friday, September 27th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $200.43.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the previous year, the business earned $1.74 earnings per share. The firm’s quarterly revenue was up 20.1% on a year-over-year basis. Sell-side analysts forecast that CME Group Inc will post 6.79 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th were given a $0.75 dividend. The ex-dividend date was Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. CME Group’s payout ratio is 43.99%.
In related news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the transaction, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sean Tully sold 7,200 shares of CME Group stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the completion of the transaction, the insider now directly owns 19,923 shares in the company, valued at $4,445,418.99. The disclosure for this sale can be found here. Over the last quarter, insiders sold 57,126 shares of company stock valued at $11,752,684. 1.20% of the stock is owned by company insiders.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Read More: What is the Quick Ratio?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.